اکثر مکاتبات کومش از طریق ایمیل سایت می باشد. لطفا Spam ایمیل خود را نیز چک نمایید.
   [Home ] [Archive]   [ فارسی ]  
:: ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
Subscription::
Contact us::
Site Facilities::
Webmail::
Editorial Board::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 25, Issue 5 (Sep and Oct 2023 2023) ::
Koomesh 2023, 25(5): 73-73 Back to browse issues page
Fullerene nanoparticle as a therapeutic agent for protection of neurovascular unit in cerebral ischemia-reperfusion injuries
Mohammad Taghi Mohammadi , Mahsa Sarami Foroshani , Zeinab Sadat Sobhani , Masiha Aryafar , Shamsi Darabi , Javad Rasoli Vani
Abstract:   (300 Views)
Introduction: Fullerene (C60), the third spherical allotrope of carbon, can remove various free radicals in the biological milieus more efficiently than cellular antioxidants. We conducted a study to determine the effectiveness of polyhydroxylated fullerenes (C60 (OH) 18-22), also known as fullerenol, in protecting the brain from injury caused by cerebral ischemia-reperfusion (IR) during an experimental model of ischemic stroke.
Methods and Materials: We randomly assigned Male Wistar rats into sham, control ischemic, pre-treated ischemic, and post-treated ischemic groups. Cerebral IR injury was induced by occlusion of the middle cerebral artery (MCA) for 90 minutes followed by 24-hour reperfusion. Rats were administered fullerenol 5mg/kg, intraperitoneally, 30min before induction of IR in the pre-treated ischemic group and immediately after termination of MCA occlusion in the post-treated ischemic group. Brain infarction and edema, blood-brain-barrier (BBB) permeability, and mRNA expression levels of MMP-9, IL-6, γ-glutamyl transpeptidase (GGT), P53, and aquaporin-1 as well as oxidative stress markers were determined after the termination of reperfusion phase.
Results: Based on our research, it was discovered that fullerenol reduced brain infarction caused by ischemia in rats. Additionally, it reduced the amount of oxidative damage to the brain affected by ischemia and boosted the antioxidant system of the affected brain by increasing the activity of antioxidant enzymes. Fullerenol decreased GGT and P53 and aquaporin-1 expression in the ischemic areas in cerebral IR injuries. Using fullerenol nanoparticles during cerebral IR was found to attenuate the ischemia-induced brain edema and also protect the integrity of BBB against brain IR injuries through inhibition of MMP-9 and IL-6 expression.
Conclusions: Fullerenol nanoparticles can decrease brain infarction and edema as well as BBB disruption by protecting brain microvasculature and BBB integrity during IR injuries. Based on our findings, we recommend using this nanoparticle for therapeutic purposes to decrease cerebral IR injuries following an ischemic stroke.

 
Keywords: Ischemic stroke, Blood-brain barrier, inflammation, oxidative stress, Fullerenol
Full-Text [PDF 330 kb]   (42 Downloads)    
Type of Study: Research | Subject: General
Received: 2023/11/23 | Accepted: 2023/08/23 | Published: 2023/08/23
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mohammadi M T, Sarami Foroshani M, Sobhani Z S, Aryafar M, Darabi S, Rasoli Vani J. Fullerene nanoparticle as a therapeutic agent for protection of neurovascular unit in cerebral ischemia-reperfusion injuries. Koomesh 2023; 25 (5) :73-73
URL: http://koomeshjournal.semums.ac.ir/article-1-8181-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 25, Issue 5 (Sep and Oct 2023 2023) Back to browse issues page
کومش Koomesh
Persian site map - English site map - Created in 0.04 seconds with 38 queries by YEKTAWEB 4645